Medical Developments International has released a press release.
MVP Announces $30m Capital Raise and FY22 Guidance
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
In the deck
Earlier from Medical Developments International
- MVP signs new Penthrox licensing agreement in Canada
- US FDA Investor Presentation
- Green Whistle gets the Green Light - FDA Clears US Trial
- MVP FY22 Half Year Investor Presentation
- FY22 Half Year Report and Accounts
Later from Medical Developments International
- Investor Presentation - $30m Capital Raise and FY22 Guidance
- Prospectus - Entitlement Offer and Options
- Security Class Suspension from Quotation MVPO
- FY22 Full Year Accounts
- MVP Announces FY22 Full Year Results
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International